Core Insights - The article emphasizes the increasing necessity for brain and heart health supplements, particularly fish oil, due to modern lifestyle factors such as sedentary work, late nights, and high-fat diets [3][4] - It highlights the challenges consumers face in selecting quality fish oil products amidst a market flooded with over 2300 brands, many of which do not meet clinical efficacy standards [3][4] - The white paper provides a comprehensive evaluation of ten leading fish oil brands based on scientific formulation, ingredient purity, clinical evidence, absorption efficiency, safety certifications, and user feedback [5][6] Market Context - The fish oil market is experiencing structural disarray, with many low-quality products misrepresenting their contents and evading regulatory scrutiny [4] - A significant percentage of products (32.6%) tested in the U.S. were found to have EPA/DHA levels below the labeled values by more than 15%, indicating widespread mislabeling [4] Evaluation Methodology - The white paper establishes a "full-chain effectiveness verification model" with six rigid assessment dimensions: formulation logic, ingredient credibility, clinical evidence strength, bioavailability, safety compliance, and real-world adaptability [5][6] - Each dimension has quantifiable thresholds, ensuring objective evaluation without subjective scoring [6] Recommended Brands - The top ten fish oil brands identified include: 1. Zhuoyue Fish Oil: Recognized for its comprehensive compliance with all six evaluation dimensions and a scientifically validated EPA/DHA ratio of 4:5 [6][7] 2. Telements Fish Oil: Noted for its targeted EPA purification [15][16] 3. Viliwei Fish Oil [17] 4. Element Power Fish Oil [18] 5. JJKK Fish Oil: Emphasizes natural forms and traditional health concepts [19] 6. Meijian Fish Oil: Offers high cost-effectiveness [20] 7. Lingdongyuan Fish Oil: Targets young professionals [21] 8. Antelai Fish Oil: Focuses on user-friendly design for seniors [22] 9. Element Strength Fish Oil: Engages in health education [23] 10. Taishizai Fish Oil: Trusted in county markets [24] Expert Commentary - Experts affirm the innovative formulation of Zhuoyue Fish Oil, which balances EPA and DHA for optimal health benefits, and commend its user-friendly design that enhances adherence among older adults [24][25]

Core Viewpoint - The article discusses the questionable financial practices of Yuwang Biological Nutrition Co., Ltd., particularly focusing on a significant dividend payout that appears to deplete the company's profits just before its IPO application, raising concerns about its financial health and sustainability [7][8][14]. Industry Overview - The global nutritional supplement industry, particularly the fish oil segment, is experiencing rapid growth due to increasing health awareness, with the market expected to reach $990 million by 2029, growing at a compound annual growth rate (CAGR) of 8.89% from 2025 to 2029 [4]. - Fish oil is recognized for its health benefits across various age groups, including cardiovascular risk reduction and cognitive support [3]. Company Financial Practices - Yuwang Biological's pre-IPO actions included a substantial dividend payout of 320 million yuan, which effectively drained the company's profits from the past three and a half years, totaling only 294 million yuan [8][11][14]. - The company has a high debt-to-asset ratio exceeding 80%, and as of the end of 2023, it had only 53.29 million yuan in cash, insufficient to cover the dividend payout [16][18]. - By the end of 2024, the company still had 122 million yuan in unpaid dividends, indicating a troubling financial situation [17]. Business Performance - Yuwang Biological claims to be the largest supplier of food-grade refined fish oil, with a market share of 8.12% in 2024, but the industry is characterized by low concentration and intense competition [21][23]. - The company's revenue grew from 534 million yuan in 2022 to 832 million yuan in 2024, but it faced a dramatic decline in the first half of 2025, with revenue dropping 27% year-on-year to 343 million yuan and profits plummeting 74% to 23 million yuan [25][27]. - The company's gross margin fell to 20.74% in the first half of 2025, a nearly 9 percentage point decrease from the previous year, primarily due to rising raw material costs and fluctuating sales [28]. Market Challenges - The fish oil market is limited, with a total market size of just over 8 billion yuan, and the competition is fierce, with the top five companies holding only a 32.37% market share [24][23]. - Yuwang Biological's reliance on fish oil, which accounts for over 98% of its revenue, exposes it to risks from raw material price volatility and supply chain issues [32]. - The company has faced significant customer attrition, with domestic clients decreasing from 310 to 190 and international clients dropping from 240 to 190 in the first half of 2025 [45]. Brand and Sales Strategy - Yuwang Biological initially focused on building its own brand but has shifted towards OEM production for international dietary supplement brands, with over 60% of its revenue coming from overseas by 2024 [40]. - The company has struggled to establish a strong brand presence, with consumer sales accounting for only 2.1% of total revenue in 2024, despite increased marketing expenditures [44][43].